A case of CML is described in which comprehensive molecular analysis, including targeted next-generation sequencing, revealed a single <i>ASXL1</i> mutation cooperating with an e6a2 <i>BCR-ABL1</i> fusion transcript at blast crisis. This evidence concerns the gene ASXL1 and chronic myelogenous leukemia, BCR-ABL1 positive.